Patents are often the bedrock of new innovation, and a suite of patents defining how AI-generated music can be created, licensed and monetized has hit the market — with multiple AI companies lined up to license them. Music IP Holdings, a company formed last year out of a strategic partnership with Universal Music Group and the
The AI tool was trained on scientific publication-patent pairs.Credit: IB Photography/Alamy Investors and technology-transfer offices expend enormous effort trying to spot commercially promising research before it reaches the point of patenting. Now, a machine-learning tool is aiming to speed up this process by scoring how ‘patent-like’ a scientific paper is — months or years before
Half a century ago, biochemists Georges Köhler and César Milstein kicked off a revolution in medicine. Their 1975 paper described how to mass-produce monoclonal antibodies: proteins that can be designed to recognize and bind specifically to almost any protein target1. These antibodies have since become a workhorse of biological research and the basis of blockbuster
